Source: BioSpace

Encision: Encision Reports Third Quarter Fiscal Year 2024 Results

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2024 third quarter that ended December 31, 2023.

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
Greg Trudel's photo - President & CEO of Encision

President & CEO

Greg Trudel

CEO Approval Rating

87/100

Read more